Loading…

Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin

•TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subun...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2023-11, Vol.41 (46), p.6834-6841
Main Authors: Liu, Xu-Yang, Wei, Dong-Kui, Li, Zhi-Ying, Lu, Jian-Sheng, Xie, Xin-Mei, Yu, Yun-Zhou, Pang, Xiao-Bin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863
container_end_page 6841
container_issue 46
container_start_page 6834
container_title Vaccine
container_volume 41
creator Liu, Xu-Yang
Wei, Dong-Kui
Li, Zhi-Ying
Lu, Jian-Sheng
Xie, Xin-Mei
Yu, Yun-Zhou
Pang, Xiao-Bin
description •TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subunit vaccine against TeNT. Tetanus toxin (TeNT) is a protein toxin produced by Clostridium tetani bacteria, which causes hyperreflexia and rhabdomyolysis by spastic paralysis. Like botulinum neurotoxin, TeNT comprises a heavy chain (HC) and a light chain (LC) linked via an interchain disulfide bond, which include the following three functional domains: a receptor-binding domain (Hc), a translocation domain (HN), and a catalytic domain (LC). Herein, we produced and characterized three functional domains of TeNT and three types of TeNT-derived L-HN fragments (TL-HN, TL-GS-HN and TL-2A-HN), which contained L and HN domains but lacked the Hc domain. The immunological effects of these different functional domains or fragments of TeNT were explored in an animal model. Our investigations showed the TL-HN functional fragment provided the best immunoprotection among all the TeNT functional domains. The TL–HN fragment, as a protective antigen, induced the highest levels of neutralizing antibodies, indicating that it might contain some crucial epitopes. Further experiments revealed that the protective effect of TL-HN was superior to that of the THc, TL, or THN fragments, either individually or in combination. Therefore, the TL-HN fragment exerts an important function in immune protection against tetanus toxin, providing a good basis for the development of TeNT vaccines or antibodies, and could serve as a promising subunit vaccine to replace THc or tetanus toxoid (TT).
doi_str_mv 10.1016/j.vaccine.2023.09.032
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153674919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X23011027</els_id><sourcerecordid>2883296783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863</originalsourceid><addsrcrecordid>eNqFkU9vFCEYh4nR2G31I2hIvHiZKX9mGDgZ02jbZFMvbdIbYeCdymYHKjAb--1lu6sHLz0RfnneH-R9EPpASUsJFeebdmes9QFaRhhviWoJZ6_QisqBN6yn8jVaESa6pqPk_gSd5rwhhPScqrfohA-SCtF3K6Sv53kJ8QGCt748YRMc9s_RY4oFbPEx4Djh8hPwtITnu9ni23VzdYOnZB5mCAU7SH4HrgZxxgWKCUvGJf724R16M5lthvfH8wzdff92e3HVrH9cXl98XTeWD11pBGWM03GcJumMmiwHQ0U3ODuMRjlupaLKKMs6zkY3dsKN1o6jMDVkk5CCn6HPh9767V8L5KJnny1styZAXLLmtOdi6GrNiyiTQy97pkhX0U__oZu4pLqAPSU5U2KQvFL9gbIp5pxg0o_JzyY9aUr0Xpbe6KMsvZelidJVVp37eGxfxhncv6m_dirw5QBA3dzOQ9LZeggWnE9VjXbRv_DEHxB2qUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2883296783</pqid></control><display><type>article</type><title>Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin</title><source>ScienceDirect Journals</source><creator>Liu, Xu-Yang ; Wei, Dong-Kui ; Li, Zhi-Ying ; Lu, Jian-Sheng ; Xie, Xin-Mei ; Yu, Yun-Zhou ; Pang, Xiao-Bin</creator><creatorcontrib>Liu, Xu-Yang ; Wei, Dong-Kui ; Li, Zhi-Ying ; Lu, Jian-Sheng ; Xie, Xin-Mei ; Yu, Yun-Zhou ; Pang, Xiao-Bin</creatorcontrib><description>•TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subunit vaccine against TeNT. Tetanus toxin (TeNT) is a protein toxin produced by Clostridium tetani bacteria, which causes hyperreflexia and rhabdomyolysis by spastic paralysis. Like botulinum neurotoxin, TeNT comprises a heavy chain (HC) and a light chain (LC) linked via an interchain disulfide bond, which include the following three functional domains: a receptor-binding domain (Hc), a translocation domain (HN), and a catalytic domain (LC). Herein, we produced and characterized three functional domains of TeNT and three types of TeNT-derived L-HN fragments (TL-HN, TL-GS-HN and TL-2A-HN), which contained L and HN domains but lacked the Hc domain. The immunological effects of these different functional domains or fragments of TeNT were explored in an animal model. Our investigations showed the TL-HN functional fragment provided the best immunoprotection among all the TeNT functional domains. The TL–HN fragment, as a protective antigen, induced the highest levels of neutralizing antibodies, indicating that it might contain some crucial epitopes. Further experiments revealed that the protective effect of TL-HN was superior to that of the THc, TL, or THN fragments, either individually or in combination. Therefore, the TL-HN fragment exerts an important function in immune protection against tetanus toxin, providing a good basis for the development of TeNT vaccines or antibodies, and could serve as a promising subunit vaccine to replace THc or tetanus toxoid (TT).</description><identifier>ISSN: 0264-410X</identifier><identifier>ISSN: 1873-2518</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2023.09.032</identifier><identifier>PMID: 37816654</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>active sites ; Animal models ; Animals ; Antibodies ; Antibodies, Bacterial - blood ; Antibodies, Bacterial - immunology ; Antibodies, Neutralizing - immunology ; Antigens ; Botulinum toxin ; Chemical bonds ; Clostridium tetani ; Cytoplasm ; disulfide bonds ; domain ; E coli ; Epitopes ; Female ; Fragments ; Functional domain ; Immune protection ; Immunization ; Immunogenicity ; Immunology ; Laboratory animals ; Mice ; Mice, Inbred BALB C ; Neurotoxicity ; Neurotoxins ; Paralysis ; Peptide Fragments - immunology ; Plasmids ; Poisoning ; Protective antigen ; protective effect ; Proteins ; Rhabdomyolysis ; Subunit vaccine ; subunit vaccines ; Tetanus ; Tetanus - immunology ; Tetanus - prevention &amp; control ; Tetanus toxin ; Tetanus Toxin - immunology ; TL-HN fragment ; Toxins ; Translocation ; Vaccines</subject><ispartof>Vaccine, 2023-11, Vol.41 (46), p.6834-6841</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><rights>2023. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37816654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Xu-Yang</creatorcontrib><creatorcontrib>Wei, Dong-Kui</creatorcontrib><creatorcontrib>Li, Zhi-Ying</creatorcontrib><creatorcontrib>Lu, Jian-Sheng</creatorcontrib><creatorcontrib>Xie, Xin-Mei</creatorcontrib><creatorcontrib>Yu, Yun-Zhou</creatorcontrib><creatorcontrib>Pang, Xiao-Bin</creatorcontrib><title>Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>•TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subunit vaccine against TeNT. Tetanus toxin (TeNT) is a protein toxin produced by Clostridium tetani bacteria, which causes hyperreflexia and rhabdomyolysis by spastic paralysis. Like botulinum neurotoxin, TeNT comprises a heavy chain (HC) and a light chain (LC) linked via an interchain disulfide bond, which include the following three functional domains: a receptor-binding domain (Hc), a translocation domain (HN), and a catalytic domain (LC). Herein, we produced and characterized three functional domains of TeNT and three types of TeNT-derived L-HN fragments (TL-HN, TL-GS-HN and TL-2A-HN), which contained L and HN domains but lacked the Hc domain. The immunological effects of these different functional domains or fragments of TeNT were explored in an animal model. Our investigations showed the TL-HN functional fragment provided the best immunoprotection among all the TeNT functional domains. The TL–HN fragment, as a protective antigen, induced the highest levels of neutralizing antibodies, indicating that it might contain some crucial epitopes. Further experiments revealed that the protective effect of TL-HN was superior to that of the THc, TL, or THN fragments, either individually or in combination. Therefore, the TL-HN fragment exerts an important function in immune protection against tetanus toxin, providing a good basis for the development of TeNT vaccines or antibodies, and could serve as a promising subunit vaccine to replace THc or tetanus toxoid (TT).</description><subject>active sites</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antibodies, Bacterial - immunology</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antigens</subject><subject>Botulinum toxin</subject><subject>Chemical bonds</subject><subject>Clostridium tetani</subject><subject>Cytoplasm</subject><subject>disulfide bonds</subject><subject>domain</subject><subject>E coli</subject><subject>Epitopes</subject><subject>Female</subject><subject>Fragments</subject><subject>Functional domain</subject><subject>Immune protection</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Immunology</subject><subject>Laboratory animals</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neurotoxicity</subject><subject>Neurotoxins</subject><subject>Paralysis</subject><subject>Peptide Fragments - immunology</subject><subject>Plasmids</subject><subject>Poisoning</subject><subject>Protective antigen</subject><subject>protective effect</subject><subject>Proteins</subject><subject>Rhabdomyolysis</subject><subject>Subunit vaccine</subject><subject>subunit vaccines</subject><subject>Tetanus</subject><subject>Tetanus - immunology</subject><subject>Tetanus - prevention &amp; control</subject><subject>Tetanus toxin</subject><subject>Tetanus Toxin - immunology</subject><subject>TL-HN fragment</subject><subject>Toxins</subject><subject>Translocation</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkU9vFCEYh4nR2G31I2hIvHiZKX9mGDgZ02jbZFMvbdIbYeCdymYHKjAb--1lu6sHLz0RfnneH-R9EPpASUsJFeebdmes9QFaRhhviWoJZ6_QisqBN6yn8jVaESa6pqPk_gSd5rwhhPScqrfohA-SCtF3K6Sv53kJ8QGCt748YRMc9s_RY4oFbPEx4Djh8hPwtITnu9ni23VzdYOnZB5mCAU7SH4HrgZxxgWKCUvGJf724R16M5lthvfH8wzdff92e3HVrH9cXl98XTeWD11pBGWM03GcJumMmiwHQ0U3ODuMRjlupaLKKMs6zkY3dsKN1o6jMDVkk5CCn6HPh9767V8L5KJnny1styZAXLLmtOdi6GrNiyiTQy97pkhX0U__oZu4pLqAPSU5U2KQvFL9gbIp5pxg0o_JzyY9aUr0Xpbe6KMsvZelidJVVp37eGxfxhncv6m_dirw5QBA3dzOQ9LZeggWnE9VjXbRv_DEHxB2qUA</recordid><startdate>20231102</startdate><enddate>20231102</enddate><creator>Liu, Xu-Yang</creator><creator>Wei, Dong-Kui</creator><creator>Li, Zhi-Ying</creator><creator>Lu, Jian-Sheng</creator><creator>Xie, Xin-Mei</creator><creator>Yu, Yun-Zhou</creator><creator>Pang, Xiao-Bin</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope></search><sort><creationdate>20231102</creationdate><title>Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin</title><author>Liu, Xu-Yang ; Wei, Dong-Kui ; Li, Zhi-Ying ; Lu, Jian-Sheng ; Xie, Xin-Mei ; Yu, Yun-Zhou ; Pang, Xiao-Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>active sites</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antibodies, Bacterial - immunology</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antigens</topic><topic>Botulinum toxin</topic><topic>Chemical bonds</topic><topic>Clostridium tetani</topic><topic>Cytoplasm</topic><topic>disulfide bonds</topic><topic>domain</topic><topic>E coli</topic><topic>Epitopes</topic><topic>Female</topic><topic>Fragments</topic><topic>Functional domain</topic><topic>Immune protection</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Immunology</topic><topic>Laboratory animals</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neurotoxicity</topic><topic>Neurotoxins</topic><topic>Paralysis</topic><topic>Peptide Fragments - immunology</topic><topic>Plasmids</topic><topic>Poisoning</topic><topic>Protective antigen</topic><topic>protective effect</topic><topic>Proteins</topic><topic>Rhabdomyolysis</topic><topic>Subunit vaccine</topic><topic>subunit vaccines</topic><topic>Tetanus</topic><topic>Tetanus - immunology</topic><topic>Tetanus - prevention &amp; control</topic><topic>Tetanus toxin</topic><topic>Tetanus Toxin - immunology</topic><topic>TL-HN fragment</topic><topic>Toxins</topic><topic>Translocation</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Xu-Yang</creatorcontrib><creatorcontrib>Wei, Dong-Kui</creatorcontrib><creatorcontrib>Li, Zhi-Ying</creatorcontrib><creatorcontrib>Lu, Jian-Sheng</creatorcontrib><creatorcontrib>Xie, Xin-Mei</creatorcontrib><creatorcontrib>Yu, Yun-Zhou</creatorcontrib><creatorcontrib>Pang, Xiao-Bin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Xu-Yang</au><au>Wei, Dong-Kui</au><au>Li, Zhi-Ying</au><au>Lu, Jian-Sheng</au><au>Xie, Xin-Mei</au><au>Yu, Yun-Zhou</au><au>Pang, Xiao-Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2023-11-02</date><risdate>2023</risdate><volume>41</volume><issue>46</issue><spage>6834</spage><epage>6841</epage><pages>6834-6841</pages><issn>0264-410X</issn><issn>1873-2518</issn><eissn>1873-2518</eissn><abstract>•TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subunit vaccine against TeNT. Tetanus toxin (TeNT) is a protein toxin produced by Clostridium tetani bacteria, which causes hyperreflexia and rhabdomyolysis by spastic paralysis. Like botulinum neurotoxin, TeNT comprises a heavy chain (HC) and a light chain (LC) linked via an interchain disulfide bond, which include the following three functional domains: a receptor-binding domain (Hc), a translocation domain (HN), and a catalytic domain (LC). Herein, we produced and characterized three functional domains of TeNT and three types of TeNT-derived L-HN fragments (TL-HN, TL-GS-HN and TL-2A-HN), which contained L and HN domains but lacked the Hc domain. The immunological effects of these different functional domains or fragments of TeNT were explored in an animal model. Our investigations showed the TL-HN functional fragment provided the best immunoprotection among all the TeNT functional domains. The TL–HN fragment, as a protective antigen, induced the highest levels of neutralizing antibodies, indicating that it might contain some crucial epitopes. Further experiments revealed that the protective effect of TL-HN was superior to that of the THc, TL, or THN fragments, either individually or in combination. Therefore, the TL-HN fragment exerts an important function in immune protection against tetanus toxin, providing a good basis for the development of TeNT vaccines or antibodies, and could serve as a promising subunit vaccine to replace THc or tetanus toxoid (TT).</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>37816654</pmid><doi>10.1016/j.vaccine.2023.09.032</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2023-11, Vol.41 (46), p.6834-6841
issn 0264-410X
1873-2518
1873-2518
language eng
recordid cdi_proquest_miscellaneous_3153674919
source ScienceDirect Journals
subjects active sites
Animal models
Animals
Antibodies
Antibodies, Bacterial - blood
Antibodies, Bacterial - immunology
Antibodies, Neutralizing - immunology
Antigens
Botulinum toxin
Chemical bonds
Clostridium tetani
Cytoplasm
disulfide bonds
domain
E coli
Epitopes
Female
Fragments
Functional domain
Immune protection
Immunization
Immunogenicity
Immunology
Laboratory animals
Mice
Mice, Inbred BALB C
Neurotoxicity
Neurotoxins
Paralysis
Peptide Fragments - immunology
Plasmids
Poisoning
Protective antigen
protective effect
Proteins
Rhabdomyolysis
Subunit vaccine
subunit vaccines
Tetanus
Tetanus - immunology
Tetanus - prevention & control
Tetanus toxin
Tetanus Toxin - immunology
TL-HN fragment
Toxins
Translocation
Vaccines
title Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A16%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunogenicity%20and%20immunoprotection%20of%20the%20functional%20TL-HN%20fragment%20derived%20from%20tetanus%20toxin&rft.jtitle=Vaccine&rft.au=Liu,%20Xu-Yang&rft.date=2023-11-02&rft.volume=41&rft.issue=46&rft.spage=6834&rft.epage=6841&rft.pages=6834-6841&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2023.09.032&rft_dat=%3Cproquest_cross%3E2883296783%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2883296783&rft_id=info:pmid/37816654&rfr_iscdi=true